Environment-gene interactions in intestinal cancer

European Journal of Cancer Prevention

Volumn 11, Issue SUPPL. 2, 2002, Pages

  Augenlicht, Leonard H ^a   Heerdt, Barbara G ^a   Mariadason, John M ^a   Yang, WanCai ^a   Wilson, Andrew J ^a   Fragale, Alessandra ^a   Velcich, Anna ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Differentiation; Fatty acids; Genomics; Mitochondria; Mucin

Indexed keywords

MUCIN;

CELL DIFFERENTIATION; COLON CANCER; CONFERENCE PAPER; ENVIRONMENT; GENE DISRUPTION; GENE INTERACTION; GENETIC PREDISPOSITION; GENOMICS; GENOTOXICITY; HUMAN; INTESTINE CANCER; MEMBRANE POTENTIAL; METABOLIC ACTIVATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL TRANSFORMATION; COLORECTAL TUMOR; DIET; DISEASE MODEL; ENVIRONMENTAL EXPOSURE; FEMALE; GENETICS; INCIDENCE; INTESTINE MUCOSA; MALE; MOUSE; PATHOLOGY; PEDIGREE; PROGNOSIS; RESEARCH; REVIEW; RISK FACTOR; SURVIVAL RATE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DIET; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INTESTINAL MUCOSA; MALE; MICE; PEDIGREE; PROGNOSIS; RESEARCH; RISK FACTORS; SURVIVAL RATE;

EID: 0036702272     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Aslam F, Augenlicht L, Velcich A (2001). The Sp family of transcription factors in the regulation of the human and mouse MUC2 gene promoters. Cancer Res 61: 570-6.
2. Augenlicht LH, Heerdt BG (2001). Mitochondria: Integrators in tumorigenesis? Nature Genet 28: 104-5.
3. Augenlicht LH, Kobrin D (1982). Cloning and screening of sequences expressed in a mouse colon tumor. Cancer Res 42: 1088-93.
4. Augenlicht LH, Kobrin D, Pavlovec A, Royston ME (1984). Elevated expression of an endogenous retroviral long terminal repeat in a mouse colon tumor. J Biol Chem 259: 1842-7.
5. Augenlicht LH, Halsey H (1985). Expression of a mouse long terminal repeat is cell cycle-linked. Proc Natl Acad Sci USA 82: 1946-9.
6. Augenlicht LH, Wahrman MZ, Halsey H, Anderson L, Taylor J, Lipkin M (1987). Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro. Cancer Res 47: 6017-21.
7. Augenlicht LH, Taylor J, Anderson L, Lipkin M (1991). Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer. Proc Natl Acad Sci USA 88: 3286-9.
8. Augenlicht LH, Anthony GM, Church TL, et al. (1999). Short chain fatty acid metabolism, apoptosis and Apc initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res 59: 6005-9.
9. Bordonaro M, Mariadason JM Aslam F, Heerdt BG, Augenlicht LH (1999). Butyrate induced cell cycle arrest and apoptotic cascade in colonic carcinoma cells: Modulation of the B-catenin-Tcf pathway, and concordance with effects of sulindac and trichostatin, but not curcumin. Cell Growth Differ 10: 713-20.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995). Mice lacking p21 cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-84.
11. El-Deiry WS, Tokino T, Waldman T et al. (1995). Topological control of p21 waf1/cip1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-19.
12. Femino AM, Fay FS, Fogarty K, Singer RH (1998). Visualization of single RNA transcripts in situ. Science 280: 585-90.
13. Giardiello FM, Hamilton SR, Knish AJ et al. (1993). Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313-16.
14. Green DR, Reed JC (1998). Mitochondria and Apoptosis. Science 281: 1309-16.
15. He T-C, Sparks AB, Rago C, et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509-12.
16. Heerdt BG, Halsey HK, Lipkin M, Augenlicht LH (1990). Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Cancer Res 50: 1596-600.
17. Heerdt BG, Chen JS, Stewart LR, Augenlicht LH (1994a). Polymorphisms, but lack of mutations or instability, in the promotor region of the mitochondrial genome in human colonic tumors. Cancer Res 54: 3912-15.
18. Heerdt BG, Houston MA, Augenlicht LH (1994b). Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 54: 3288-94.
19. Heerdt BG, Houston MA, Rediske JJ, Augenlicht LH (1996). Steady-state levels of mitochondrial messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells. Cell Growth Differ 7: 101-6.
20. Heerdt BG, Houston MA, Augenlicht LH (1997). Short chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 8: 523-32.
21. Heerdt BG, Houston MA, Anthony GM, Augenlicht LH (1998). Mitochondrial membrane potential in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res 58: 2869-75.
22. Herold KM, Rothberg PG (1988). Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene 3: 423-8.
23. Heruth DP, Zirnstein GW, Bradley IF. Rothberg PG (1993). Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem 268: 20466-72.
24. Labayle D, Fischer D, Vielh P, et al. (1991). Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101: 635-9.
25. Mariadason JM, Corner GA, Augenlicht LH (2000a). Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: Comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60: 4561-72.
26. Mariadason JM, Rickard KL, Barkla DH, Augenlicht LH, Gibson PR (2000b). Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J Cell Physiol 183: 347-354.
27. Mariadason JM, Bordonaro M, Aslam F, Shi L, Kuraguchi M, Velcich A, Augenlicht LH (2001). Down-regulation of B-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res 61: 3465-71.
28. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK (1993). Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80: 1618-19.
29. Pretlow TP, Siddiki B, Augenlicht LH, Pretlow TG, Kim YS (1999). Aberrant crypt foci (ACF)- earliest recognized players or innocent bystanders in colon carcinogenesis. In Colorectal Cancer: Molecular Mechanisms, Premalignant State, and its Prevention; Kluwer Academic, Lancaster.
30. Roediger WEW (1982). Utilization of metabolic fuels by the colonic mucosa. Gastroenterology 83: 424-9.
31. Roediger WEW (1988). Bacterial short-chain fatty acids and mucosal diseases of the colon. Br J Surg 75: 346-8.
32. Royston ME, Augenlicht LH (1983). Biotinated probe containing a long-terminal repeat hybridized to a mouse colon tumor and normal tissue. Science 222: 1339-41.
33. Shiff SJ, Rigas B (1997). Nonsteroidal antiinflammatory drugs and colorectal cancer: Evolving concepts in their chemopreventive actions. Gastroenterology 113: 1992-8.
34. Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ (1997). Inhibition of cyclooxygenase: A novel approach to cancer prevention. Proc Soc Exp Biol Med 216: 201-10.
35. Taylor CW, Kim YS, Childress-Fields KE, Yeoman LC (1992). Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines. Cancer Lett 62: 95-105.
36. Velcich A, Augenlicht LH (1993). Regulated expression of an intestinal mucin gene in HT29 colonic carcinoma cells. J Biol Chem 268: 13956-13961.
37. Velcich A, Palumbo L, Selleri L, Evans G, Augenlicht L (1997). Organization and regulatory aspects of the human intestinal mucin gene (MUC2) locus. J Biol Chem 272: 7968-76.
38. Velcich A, Yang W, Heyer J, et al. (2002). Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295: 1726-9.
39. Waddell WR, Ganser GF, Ej C, Loughry RW (1989). Sulindac polyposis of the colon. Am J Surg 157: 173-9.
40. Yang WC, Mathew J, Velcich A, et al. (2001a). Targeted inactivation of the p21 WAF1/cip1 gene enhances Apc initiated tumor formation and the tumor promoting activity of a Western-style high risk diet by altering cell maturation in the intestinal mucosa. Cancer Res 61: 565-9.
41. Yang WC, Velcich A, Mariadason J et al. (2001b). p21WAF1/cip1 is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res 61: 6297-302.